What is XPH's relative strength rating?

Relative strength percentiles for XPH are not available for the current snapshot date. TickerStance publishes RS ratings daily after each session close; check back after the next pipeline run.

What sector is XPH in?

XPH is classified under the Other sector per the TickerStance sector-classification pipeline, which maps U.S. equities to GICS-aligned sectors using exchange SIC codes and Massive Finance reference data.

Is XPH in a leading sector?

Sector RS percentile is not available for Other at this snapshot. Leading sector status (threshold: Other RS ≥ 70th percentile) cannot be determined until the next sector RS pipeline run.

XPH currently shows a 20-day average daily range (ADR%) of 1.7%, a 90-day beta versus the S&P 500 of 0.49. ADR% and ATR% are updated daily; beta is computed over a trailing 90-day window.

Does XPH have a seasonal pattern?

TickerStance computes XPH's month-by-month seasonality from its full daily price history: the average and median return for each calendar month, how often that month closed higher, and the best and worst months on record. These are historical frequencies, not forecasts — a strong seasonal month describes what XPH has tended to do in prior years, not a prediction of what comes next. The full month-by-month heatmap and win-rate table sit higher on this page.

When did XPH last report earnings?

No SEC EDGAR filings are linked to XPH in the current TickerStance fundamentals database. This can occur for tickers without a matched CIK (some ADRs, ETFs, and recently listed securities) or when the fundamentals pipeline has not yet processed this ticker.

State Street SPDR S&P Pharmaceuticals ETF (XPH)

Free

Dossier · Pro

State Street SPDR S&P Pharmaceuticals ETF · Other

$72.68▼-0.16%

Neutral · stance 47.8As of Monday, August 24, 2026, posted ~17:00 ET

XPH is not confirmed as a leader.

3m RS is unavailable, Market Stance is 47.8

Lenses litMarket-wide RS; lit = leaderboard

3 month—pctile

6 month—pctile

1 year—pctile

Classic—IBD pctile

LDR—leadership

0 of 5 lenses litLens definitions methodology

Quality filters1 of 4 pass

ADR%1.7%

A/DA

RVOL0.96×

$ Vol$8M

TODAY'S READ · AS OF 2026-08-24

As of 2026-08-24, State Street SPDR S&P Pharmaceuticals ETF (XPH) has a 3-month relative strength percentile of — within the TickerStance CS+ADRC universe (~5,000 tickers). The current market Stance is 47.8 (Neutral). Sector: Other. Average daily range 1.7%, relative volume 0.96×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.

Filed: Mar 2026

HOLDINGS

Top holdings of XPH

Top 25 holdings of XPH by portfolio weight
#	Holding	Weight	Value
1	Enliven Therapeutics Inc	2.45%	$8M
2	CORT	2.29%	$7M
3	Terns Pharmaceuticals Inc	2.16%	$7M
4	Perrigo Co PLC	2.10%	$6M
5	AXSM	2.03%	$6M
6	INVA	1.99%	$6M
7	MRK	1.98%	$6M
8	PFE	1.97%	$6M
9	ELAN	1.96%	$6M
10	ESPR	1.95%	$6M
11	EWTX	1.95%	$6M
12	MBX	1.95%	$6M
13	DFTX	1.95%	$6M
14	BMY	1.94%	$6M
15	ANIP	1.93%	$6M
16	JNJ	1.93%	$6M
17	TARS	1.92%	$6M
18	TRVI	1.92%	$6M
19	PCRX	1.90%	$6M
20	ZTS	1.89%	$6M
21	CRNX	1.88%	$6M
22	NKTR	1.88%	$6M
23	LQDA	1.88%	$6M
24	AMRX	1.88%	$6M
25	HRMY	1.87%	$6M

Showing 25 of 55 holdings.

CONCENTRATION

Portfolio shape

20.9%Top 10 holdings

55Total holdings

50 (91%)Resolved tickers

SECTORS

Sector breakdown

Healthcare

82.3%

Other

2.0%

Unclassified

9.4%

FAQ

Fund FAQ

What does XPH hold?: XPH holds 55 positions; its three largest are CORT (2.29%), AXSM (2.03%), and INVA (1.99%) as of Mar 2026.
How concentrated is XPH?: The top 10 holdings account for 20.9% of XPH's portfolio. Diversified across many positions.
What sectors does XPH cover?: XPH's largest sector exposures are Healthcare (82.3%), Other (2.0%).
How fresh is this data?: Holdings are sourced from SEC N-PORT-P filings, published quarterly with a ~60 day lag. The most recent filing for XPH is dated Mar 2026.

Evidence · 1 of 3

Receipts behind the read

0 of 5 pass

Leadership

Is it leading?

Relative strength across horizons plus the leadership score.

—

LDR

—

StageWeinstein stage analysis

Stage 2 · Uptrend✓

Smart money

Who's accumulating?

Accumulation rating, relative volume, U/D ratio, breakout-day proof.

A/D ratingaccumulation / distribution

AAccum

RVOL todayvs 50d avg

0.96×

U/D ratiolast 50 sessions

2.09

Breakout volbreakout day vs 50d avg

50d avg $ volumeliquidity proxy

$7.6M

Risk profile

How much does it move?

Daily range, ATR, beta, and the math for a 1-ADR stop.

ADR% (20d)avg daily range

1.7%

ATR(14)14-day EMA

$1.44

ATR%ATR as % of close

1.98%

Beta vs SPY90d rolling

0.49

1-ADR stoprisk from close $72.68

$71.41−1.7%

Evidence · 3 of 3

Market backdrop

Pull-back risk if Macro turns < 60

Trend44.9Are the major indexes going up or down lately?30% weight Breadth50.6Is the rally broad-based or narrow?30% weight Leadership42.4Who's leading?20% weight Macro59.0What does the credit & rates environment say?20% weight

Stance47.8● Neutral

Public attention · XPH

Is the crowd watching?

No attention data for this ticker yet — it joins the daily scan once a baseline builds.

FAQ

Frequently asked questions

What is XPH's relative strength rating?: Relative strength percentiles for XPH are not available for the current snapshot date. TickerStance publishes RS ratings daily after each session close; check back after the next pipeline run.
What sector is XPH in?: XPH is classified under the Other sector per the TickerStance sector-classification pipeline, which maps U.S. equities to GICS-aligned sectors using exchange SIC codes and Massive Finance reference data.
Is XPH in a leading sector?: Sector RS percentile is not available for Other at this snapshot. Leading sector status (threshold: Other RS ≥ 70th percentile) cannot be determined until the next sector RS pipeline run.
How volatile is XPH?: XPH currently shows a 20-day average daily range (ADR%) of 1.7%, a 90-day beta versus the S&P 500 of 0.49. ADR% and ATR% are updated daily; beta is computed over a trailing 90-day window.
Does XPH have a seasonal pattern?: TickerStance computes XPH's month-by-month seasonality from its full daily price history: the average and median return for each calendar month, how often that month closed higher, and the best and worst months on record. These are historical frequencies, not forecasts — a strong seasonal month describes what XPH has tended to do in prior years, not a prediction of what comes next. The full month-by-month heatmap and win-rate table sit higher on this page.
When did XPH last report earnings?: No SEC EDGAR filings are linked to XPH in the current TickerStance fundamentals database. This can occur for tickers without a matched CIK (some ADRs, ETFs, and recently listed securities) or when the fundamentals pipeline has not yet processed this ticker.

Loading ticker…

XPH monthly seasonality strip
	Jan	Feb	Mar	Apr	May	Jun	Jul	Aug	Sep	Oct	Nov	Dec
1	XPH Jan avg: 2.75% median: 2.86% win: 75% σ: 3.40% n: 4 2022-04-12 → 2026-07-31	XPH Feb avg: 0.73% median: 1.17% win: 50% σ: 4.86% n: 4 2022-04-12 → 2026-07-31	XPH Mar avg: -2.74% median: -2.31% win: 0% σ: 2.15% n: 4 2022-04-12 → 2026-07-31	XPH Apr avg: -2.55% median: -5.91% win: 40% σ: 6.68% n: 5 2022-04-12 → 2026-07-31	XPH May avg: -0.67% median: 1.11% win: 60% σ: 3.39% n: 5 2022-04-12 → 2026-07-31	XPH Jun avg: 3.21% median: 0.05% win: 60% σ: 6.24% n: 5 2022-04-12 → 2026-07-31	XPH Jul avg: 4.32% median: 2.70% win: 100% σ: 3.16% n: 5 2022-04-12 → 2026-07-31	XPH Aug avg: 3.85% median: 1.62% win: 50% σ: 8.03% n: 4 2022-04-12 → 2026-07-31 (current)	XPH Sep avg: -3.01% median: -1.99% win: 25% σ: 4.41% n: 4 2022-04-12 → 2026-07-31	XPH Oct avg: 0.71% median: 3.65% win: 75% σ: 7.09% n: 4 2022-04-12 → 2026-07-31	XPH Nov avg: 3.86% median: 2.34% win: 100% σ: 4.47% n: 4 2022-04-12 → 2026-07-31	XPH Dec avg: 0.79% median: -1.19% win: 50% σ: 8.71% n: 4 2022-04-12 → 2026-07-31

XPH monthly seasonality strip

Jan

Feb

Mar

Apr

May

Jun

Jul

Aug

Sep

Oct

Nov

Dec

XPH Jan avg: 2.75% median: 2.86% win: 75% σ: 3.40% n: 4 2022-04-12 → 2026-07-31

XPH Feb avg: 0.73% median: 1.17% win: 50% σ: 4.86% n: 4 2022-04-12 → 2026-07-31

XPH Mar avg: -2.74% median: -2.31% win: 0% σ: 2.15% n: 4 2022-04-12 → 2026-07-31

XPH Apr avg: -2.55% median: -5.91% win: 40% σ: 6.68% n: 5 2022-04-12 → 2026-07-31

XPH May avg: -0.67% median: 1.11% win: 60% σ: 3.39% n: 5 2022-04-12 → 2026-07-31

XPH Jun avg: 3.21% median: 0.05% win: 60% σ: 6.24% n: 5 2022-04-12 → 2026-07-31

XPH Jul avg: 4.32% median: 2.70% win: 100% σ: 3.16% n: 5 2022-04-12 → 2026-07-31

XPH Aug avg: 3.85% median: 1.62% win: 50% σ: 8.03% n: 4 2022-04-12 → 2026-07-31 (current)

XPH Sep avg: -3.01% median: -1.99% win: 25% σ: 4.41% n: 4 2022-04-12 → 2026-07-31

XPH Oct avg: 0.71% median: 3.65% win: 75% σ: 7.09% n: 4 2022-04-12 → 2026-07-31

XPH Nov avg: 3.86% median: 2.34% win: 100% σ: 4.47% n: 4 2022-04-12 → 2026-07-31

XPH Dec avg: 0.79% median: -1.19% win: 50% σ: 8.71% n: 4 2022-04-12 → 2026-07-31

Holding

Weight

Value

Enliven Therapeutics Inc

2.45%

$8M

CORT

2.29%

$7M

Terns Pharmaceuticals Inc

2.16%

$7M

Perrigo Co PLC

2.10%

$6M

AXSM

2.03%

$6M

INVA

1.99%

$6M

MRK

1.98%

$6M

PFE

1.97%

$6M

ELAN

1.96%

$6M

ESPR

1.95%

$6M

EWTX

1.95%

$6M

MBX

1.95%

$6M

DFTX

1.95%

$6M

BMY

1.94%

$6M

ANIP

1.93%

$6M

JNJ

1.93%

$6M

TARS

1.92%

$6M

TRVI

1.92%

$6M

PCRX

1.90%

$6M

ZTS

1.89%

$6M

CRNX

1.88%

$6M

NKTR

1.88%

$6M

LQDA

1.88%

$6M

AMRX

1.88%

$6M

HRMY

1.87%

$6M

Holdings of XPH on stock-RS leaderboards
Ticker	Weight	Lens	Rank	Stage
CORT	2.29%	6M RS	25	—
EWTX	1.95%	1Y RS	136	Stage 2
MBX	1.95%	1Y RS	41	Stage 2
DFTX	1.95%	3M RS	72	—
CRNX	1.88%	3M RS	30	Stage 2
LQDA	1.88%	6M RS	147	—
AMLX	1.79%	3M RS	10	Stage 2
OMER	1.70%	1M RS	28	—
ALMS	1.60%	1Y RS	37	—
RAPP	1.37%	1Y RS	105	Stage 2

Ticker

Weight

Lens

Rank

Stage

CORT

2.29%

6M RS

—

EWTX

1.95%

1Y RS

136

Stage 2

MBX

1.95%

1Y RS

Stage 2

DFTX

1.95%

3M RS

—

CRNX

1.88%

3M RS

Stage 2

LQDA

1.88%

6M RS

147

—

AMLX

1.79%

3M RS

Stage 2

OMER

1.70%

1M RS

—

ALMS

1.60%

1Y RS

—

RAPP

1.37%

1Y RS

105

Stage 2

XPH is not confirmed as a leader.

Top holdings of XPH

Portfolio shape

Sector breakdown

Fund FAQ

Receipts behind the read

Is it leading?

Who's accumulating?

How much does it move?

Market backdrop

Is the crowd watching?

Frequently asked questions

XPH is not confirmed as a leader.

§ Seasonality

Top holdings of XPH

Portfolio shape

Sector breakdown

What the holdings are doing

Leaders inside XPH

Theme exposure inside XPH

Funds similar to XPH

Fund FAQ

Receipts behind the read

Is it leading?

Who's accumulating?

How much does it move?

Market backdrop

Is the crowd watching?

Frequently asked questions

§ Seasonality

What the holdings are doing

Leaders inside XPH

Theme exposure inside XPH

Funds similar to XPH

State Street SPDR S&P Pharmaceuticals ETF (XPH) — Stance & relative strength

XPH is not confirmed as a leader.

Top holdings of XPH

Portfolio shape

Sector breakdown

Fund FAQ

Receipts behind the read

Is it leading?

Who's accumulating?

How much does it move?

Market backdrop

Is the crowd watching?

Frequently asked questions

State Street SPDR S&P Pharmaceuticals ETF (XPH) — Stance & relative strength

XPH is not confirmed as a leader.

Top holdings of XPH

Portfolio shape

Sector breakdown

What the holdings are doing

Leaders inside XPH

Theme exposure inside XPH

Funds similar to XPH

Fund FAQ

Receipts behind the read

Is it leading?

Who's accumulating?

How much does it move?

Market backdrop

Is the crowd watching?

Frequently asked questions

What the holdings are doing

Leaders inside XPH

Theme exposure inside XPH

Funds similar to XPH